PPARA and gastric cancer: Chen et al.41 reported that fenofibrate, a common drug used to treat severe hypertriglyceridemia and mixed dyslipidemia, altered glucose and lipid metabolism, inhibited gastric cancer cell proliferation, and promoted apoptotic gastric cancer cells through PPARα.